NCT03295227

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2017-12-06Est. Completion: 2027-12-31

Enrollment target: 37 participants

Locations

M D Anderson Cancer Center, Houston, Texas, United States

Contact

Anne S. Tsaoastsao@mdanderson.org 713-792-6363

Other microbiome trials you might be interested in

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their CaregiversCompleted

CaregiverMalignant Pleural NeoplasmMetastatic Thymic CarcinomaRecurrent Lung CarcinomaRecurrent Thymic CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8

This trial studies how well embedded palliative care works in managing symptoms in participants with stage III-IV thorac…

Columbus, United StatesCompleted Dec 5, 2019

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.